Medication info
S-One MP Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

S-One MP Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.3mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
Domestic Use: 28 tablets (14 tablets/PTP X 2) Export Use: 28 tablets (14 tablets/PTP X 2), 30 tablets/bottle
Approval status
Active

MFDS item code 201402463 · Approved 2014.05.30 · Insurance code 671805710

Summary

Main use
Treatment and prevention of gastroesophageal reflux, gastrointestinal disorders (ulcers, rebleeding, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This drug should be swallowed with a liquid such as water; do not chew or crush it. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this drug 20 mg concomitantly with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning sensation) associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Renal impairment: No dose adjustment is necessary. Use caution because there is limited experience in patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg of this drug in patients with severe hepatic impairment. Elderly patients: No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of gastroesophageal reflux, gastrointestinal disorders (ulcers, rebleeding, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers positive for Helicobacter pylori
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • rebleeding due to gastric ulcers
View approved original text

This medication is used for the treatment of erosive esophagitis due to gastroesophageal reflux disease and for maintenance therapy to prevent recurrence in patients with esophagitis. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers associated with Helicobacter pylori positivity. It assists in short-term treatment of upper gastrointestinal symptoms caused by non-steroidal anti-inflammatory drugs and is used for the treatment and prevention of gastric ulcers in patients requiring long-term non-steroidal anti-inflammatory drug therapy. It is utilized for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding after intravenous infusion. In summary, this medication is widely used for various symptoms and conditions related to gastrointestinal diseases.

Dosage and Administration

Adult dosage

This drug should be swallowed with a liquid such as water; do not chew or crush it. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this drug 20 mg concomitantly with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning sensation) associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Renal impairment: No dose adjustment is necessary. Use caution because there is limited experience in patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg of this drug in patients with severe hepatic impairment. Elderly patients: No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.

Precautions

This medication should not be used in patients who have allergic reactions to certain ingredients or have had hypersensitivity to similar medications in the past. Additionally, since side effects or interactions may occur when used in combination with certain antibiotics or antiviral agents, it is essential to consult a physician. Pregnant or breastfeeding women must consult a specialist before using this medication, and it is safer for nursing mothers not to take it. Regular check-ups are required for long-term use, especially for patients taking it for more than one year, as health conditions like magnesium levels in the blood should be periodically monitored. This medication may increase the risk of bacterial proliferation in the gastrointestinal tract due to reduced stomach acid, so if unusual symptoms such as diarrhea persist, medical personnel should be informed immediately. Moreover, various side effects such as headache, dizziness, abdominal pain, skin rash may occur in some patients, and if symptoms are severe or persist, consultation with healthcare providers is advised. Patients with a history of heart disease or those taking certain medications should use this medication with special caution, as the risk of side effects may be increased due to drug interactions. In case of overdose, there is no specific antidote, and appropriate treatment should be sought immediately at a hospital. It should be kept out of reach of children in a safe place. Finally, it is important to adhere to the prescribed dosage and duration, and to consult a specialist immediately if any unusual symptoms arise.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell's syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternum pain, facial edema, facial flushing, fatigue, fever, flu-like syndrome, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal motility disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, ear pain, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbance, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it should be kept at room temperature between 1°C and 30°C, avoiding places that are too hot or too cold.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

Domestic Use: 28 tablets (14 tablets/PTP X 2) Export Use: 28 tablets (14 tablets/PTP X 2), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.